IGC Pharma, Inc. — Director's Dealing 2021

Dec 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-12-20

Reporting Person: GRIMALDI CLAUDIA (Vice President & PFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-20	Common Stock	A	250000	$0.0	Acquired	437987	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-20	Restricted Stock Units	$0.0	A	250000	Acquired	2024-04-01	Common Stock (250000)	Direct
2021-12-20	Restricted Stock Units	$0.0	A	150000	Acquired		Common Stock (150000)	Direct

Footnotes

F1: Restricted shares of common stock equally vesting over three years starting March 31, 2022, previously reported on Form 4 Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned.

F2: Corrects ownership amount of all previous Section 16 filings of the Reporting Person since May 14, 2021, which overstated the non-derivative securities ownership by 250,000 shares.

F3: Restricted shares of common stock subject to vesting according to specific milestones set by the Company's Board of Directors.

F4: Restricted shares of common stock do not have an exercisable or expiration date. The RSUs vest when milestones are achieved.